COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1482: Articles 14811-14820  | Next

Inference of SARS-CoV-2 generation times using UK household data
Hart, W. S., Abbott, S., Endo, A., Hellewell, J., Miller, E., Andrews, N., Maini, P. K., Thompson, R. N.
10.1101/2021.05.27.21257936 — Posted: 2021-05-30
Time scale performance of rapid antigen testing for SARS-COV-2: evaluation of ten rapid antigen assays
Abusrewil, Z., Alhudiri, I. M., Kaal, H., Edin El Meshri, S., Ebrahim, F. O., Dalyoum, T., Efrefer, A. A., Ibrahim, K., Ben Elfghi, M., Abusrewil, S., Elzagheid, A.
10.1101/2021.05.27.21257868 — Posted: 2021-05-30
Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation
Lee, H. K., Knabl, L., Knabl, L., Wieser, M., Mur, A., Zabernigg, A., Schumacher, J., Kaiser, N., Furth, P. A., Hennighausen, L.
10.1101/2021.05.27.21257952 — Posted: 2021-05-30
A suitable murine model for studying respiratory coronavirus infection and therapeutic countermeasures in BSL-2 laboratories
Andrade, A. C. d. S. P., Campolina-Silva, G. H., Queiroz-Junior, C. M., de Oliveira, L. C., Lacerda, L. d. S. B., Pimenta, J. C., de Souza, F. R. O., Chaves, I. d. M., Passos, I. B., Teixeira, D. C., Bittencourt-Silva, P. G., Valadao, P. A. C., Rossi-Oliveira, L., Antunes, M. M., Figueiredo, A. F. A., Wnuk, N. T., Temerozo, J. R., Ferreira, A. C., Cramer, A., Oliveira, C. A., Duraes-Carvalho, R., Arns, C. W., Guimaraes, P. P. G., Costa, G. M. J., Menezes, G. B. d., Guatimosim, C., Silva, G. S. F. d., Souza, T. M. L., Barrioni, B. R., Pereira, M. d. M., Sousa, L. P. d., Teixeira, M. M., Costa, V. V.
10.1101/2021.05.28.446200 — Posted: 2021-05-29
SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors
Taborska, P., Lastovicka, J., Stakheev, D., Strizova, Z., Bartunkova, J., Smrz, D.
10.1101/2021.05.27.446089 — Posted: 2021-05-29
The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
Jablonska, K., Aballea, S., Toumi, M.
10.1101/2021.05.26.21257844 — Posted: 2021-05-29
Spatially refined time-varying reproduction numbers of SARS-CoV-2 in Arkansas and Kentucky and their relationship to population size and public health policy, March - November, 2020
Politis, M. D., Hua, X., Ogwara, C. A., Davies, M. R., Adebile, T. M., Sherman, M. P., Zhou, X., Chowell, G., Spaulding, A. C., Fung, I. C.-H.
10.1101/2021.05.26.21257862 — Posted: 2021-05-29
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysis
Strengert, M., Becker, M., Morilla Ramos, G., Dulovic, A., Gruber, J., Juengling, J., Luerken, K., Beigel, A., Wrenger, E., Lonnemann, G., Cossmann, A., Stankov, M. V., Dopfer-Jablonka, A., Kaiser, P. D., Traenkle, B., Rothbauer, U., Krause, G., Schneiderhan-Marra, N., Behrens, G. M. N.
10.1101/2021.05.26.21257860 — Posted: 2021-05-29
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021
Kleynhans, J., Tempia, S., Wolter, N., von Gottberg, A., Bhiman, J. N., Buys, A., Moyes, J., McMorrow, M. L., Kahn, K., Gomez-Olive, F. X., Tollman, S., Martinson, N. A., Wafawanaka, F., Lebina, L., du Toit, J., Jassat, W., Neti, M., Brauer, M., Cohen, C., the PHIRST-C Group
10.1101/2021.05.26.21257849 — Posted: 2021-05-29
Strategies to Mitigate COVID-19 Resurgence Assuming Immunity Waning: A Study for Karnataka, India
Athreya, S., Adiga, A., Lewis, B. L., Marathe, M., Rathod, N., Sundaresan, R., Swarup, S., Venkatramanan, S., Yasodharan, S.
10.1101/2021.05.26.21257836 — Posted: 2021-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).